Showing results (81-90 of 107) with videos related to

Sort By:
Pageof 11
Neurogastroenterology and Motility|January 28, 2020
Ghrelin-insulin-like growth factor-1 axis is activated via autonomic neural circuits in the non-alcoholic fatty liver diseaseTakuro Nagoya, Kenya Kamimura, Ryosuke Inoue, et al.
Hepatology International|April 16, 2021
Paris II and Rotterdam criteria are the best predictors of outcomes in patients with primary biliary cholangitis in JapanNaruhiro Kimura, Masaaki Takamura, Nobutaka Takeda, et al.
BMJ Health & Care Informatics|January 6, 2026
Unrecognised sleep disturbances in patients with cirrhosis diagnosed with a portable electroencephalogram deviceAtsushi Uchiyama, Hiroteru Kamimura, Suguru Miida, et al.
World Journal of Gastroenterology|April 28, 2015
Factors predicting aggressiveness of non-hypervascular hepatic nodules detected on hepatobiliary phase of gadolinium ethoxybenzyl diethylene-triamine-pentaacetic-acid magnetic resonance imagingTsutomu Kanefuji, Toru Takano, Takeshi Suda, et al.
Cancer Management and Research|June 14, 2019
Effective prevention of sorafenib-related vascular damage induced adverse events and maintenance of hepatic function by dried bonito broth and histidineNorihiro Sakai, Kenya Kamimura, Yoko Shinagawa-Kobayashi, et al.
Disease Models & Mechanisms|June 29, 2022
Involvement of the liver-gut peripheral neural axis in nonalcoholic fatty liver disease pathologies via hepatic HTR2ATakashi Owaki, Kenya Kamimura, Masayoshi Ko, et al.
Diseases (Basel, Switzerland)|December 27, 2024
Dasatinib and Quercetin as Senolytic Drugs Improve Fat Deposition and Exhibit Antifibrotic Effects in the Medaka Metabolic Dysfunction-Associated Steatotic Liver Disease ModelShunta Yakubo, Hiroyuki Abe, Yawen Li, et al.
FEBS Open Bio|April 16, 2019
Inhibition of sodium glucose cotransporter 2 (SGLT2) delays liver fibrosis in a medaka model of nonalcoholic steatohepatitis (NASH)Ryo Goto, Kenya Kamimura, Yoko Shinagawa-Kobayashi, et al.
Biochemical and Biophysical Research Communications|February 5, 2022
Effects of a novel selective PPARα modulator, statin, sodium-glucose cotransporter 2 inhibitor, and combinatorial therapy on the liver and vasculature of medaka nonalcoholic steatohepatitis modelAtsushi Kimura, Kenya Kamimura, Marina Ohkoshi-Yamada, et al.
FEBS Open Bio|March 8, 2018
Effect of a neural relay on liver regeneration in mice: activation of serotonin release from the gastrointestinal tractRyosuke Inoue, Kenya Kamimura, Takuro Nagoya, et al.
Pageof 11